U.S. Stock News

NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Mixed Q1 2026 Results And EU Trofinetide Setback

ACADIA Pharmaceuticals (ACAD) is back in focus after first quarter 2026 results showed 10% year over year revenue growth to US$268.1 million, alongside weaker earnings, higher expenses, and a setback for trofinetide in Europe. See our latest analysis for ACADIA Pharmaceuticals. The mixed Q1 2026 update, together with the negative EU opinion on trofinetide and leadership changes in research and development, appears to be feeding into a share price that has struggled year to date despite a...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

A Look At Xeris Biopharma Holdings (XERS) Valuation After Its Profit Turnaround And Guidance Hike

Xeris Biopharma Holdings (XERS) stock is in focus after the company reported a profitable first quarter of 2026 and raised its full year revenue guidance to US$380 million to US$390 million. See our latest analysis for Xeris Biopharma Holdings. The guidance hike and first quarter profit have come after a mixed period for the stock, with a 12.95% 1 month share price return and a 9.80% year to date share price decline. At the same time, 1 year and 3 year total shareholder returns of 28.49% and...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

Is IES Holdings (IESC) Still Fairly Valued After Strong Q2 Earnings And Share Price Surge

IES Holdings (IESC) shares have been moving after the company reported second quarter 2026 earnings, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for IES Holdings. The earnings release and the recent agreement to acquire Broadwind's Abilene facility have come alongside strong share price momentum, with a 30 day share price return of 38.13% and a 1 year total shareholder return of 165.60%. Multi year total...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

A Look At Sotera Health (SHC) Valuation After Q1 2026 Results And CEO Transition

Sotera Health (SHC) just delivered a busy first quarter, pairing 10% year-over-year revenue growth and a move back to profitability with reaffirmed 2026 guidance and a planned CEO transition. See our latest analysis for Sotera Health. The share price is US$15.67 after a 7.04% 1 month share price return. However, the 90 day share price return of 11.72% and year to date share price return of 11.42% suggest recent momentum has cooled. Even so, the 1 year total shareholder return of 18.44% and 3...
NasdaqGS:TSLA
NasdaqGS:TSLAAuto

Tesla (TSLA) Is Up 7.9% After Record Semi Deal And AI Push - Has The Bull Case Changed?

In recent weeks, Tesla has reported a rebound in China-made EV sales, secured its largest-ever Semi truck order from WattEV worth about US$100 million, posted stronger quarterly earnings with margin recovery, and advanced major AI, robotaxi and chip initiatives including the Terafab semiconductor project in Texas. Taken together with the Model Y clearing new US safety evaluations and ongoing robotaxi pilots, these developments underscore Tesla’s push to reposition itself as a vertically...
NYSE:CRI
NYSE:CRILuxury

A Look At Carter's (CRI) Valuation After Its First Quarter Earnings Beat And Upgraded Guidance

Earnings beat and guidance reset the conversation for Carter's stock Carter's (CRI) stock is back in focus after first quarter 2026 results came in ahead of analyst expectations on both revenue and profit, along with Q2 and full year guidance that surprised positively. See our latest analysis for Carter's. At a share price of $35.75, Carter's has a year to date share price return of 7.68%, while the 1 year total shareholder return stands at 7.31%. This is set against a weaker 3 year and 5...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

A Look At Payoneer Global (PAYO) Valuation After Recent Mixed Share Performance

Event context and recent share performance Payoneer Global (PAYO) has drawn attention after a period of mixed share performance, with the stock up about 4.1% over the past day and 5.2% over the past month, but showing a 20.1% decline over the past 3 months. See our latest analysis for Payoneer Global. That recent 1-day share price return of 4.1% and 30-day share price return of 5.2% sit against a weaker backdrop, with a 90-day share price return showing a 20.1% decline and a 1-year total...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

A Look At DexCom (DXCM) Valuation After Strong Q1 Growth And Upgraded Profitability Guidance

Why DexCom's latest earnings matter for investors DexCom (DXCM) just reported first quarter 2026 results, with revenue of US$1.192b and net income of US$199.5m, alongside higher margins and updated profitability guidance that put cash generation and product momentum in focus. See our latest analysis for DexCom. Despite the strong first quarter update and profitability guidance, DexCom's recent share price performance has been weak. The 90 day share price return shows a 12.95% decline and the...
NasdaqGS:NUVL
NasdaqGS:NUVLBiotechs

Assessing Nuvalent (NUVL) Valuation After NDA Milestones Guardant Alliance And Quarterly Loss

Nuvalent (NUVL) is in focus after a cluster of company updates, including first quarter earnings that showed a net loss of US$109.28 million and new detail on late stage oncology milestones. See our latest analysis for Nuvalent. At a share price of US$102.40, Nuvalent has seen mixed short term moves, with a 1 day share price return of 1.78% decline but a 1 year total shareholder return of 43.02%. This points to stronger momentum over a longer window as investors weigh the NDA progress,...
NYSE:MTN
NYSE:MTNHospitality

How Cheaper Fuel And Insider Equity Vesting At Vail Resorts (MTN) Has Changed Its Investment Story

Recently, Vail Resorts benefited from a sharp fall in crude oil prices tied to optimism about reopening the Strait of Hormuz, which could ease fuel-related cost pressures across the travel and leisure sector. An insider equity vesting by executive Julie A. DeCecco also occurred in early May, highlighting ongoing equity-based compensation alignment between management and shareholders. Next, we’ll examine how lower oil-related operating costs might influence Vail Resorts’ existing investment...
NYSE:LMND
NYSE:LMNDInsurance

A Look At Lemonade (LMND) Valuation As Renters Insurance Expands Into Two New States

Lemonade (LMND) has expanded its renters insurance into New Hampshire and West Virginia, extending its digital, app based coverage to more U.S. renters and putting the stock back on many investors’ radar. See our latest analysis for Lemonade. The renters expansion arrives after a busy few weeks, including first quarter results on 29 April that showed revenue of US$258 million and a net loss of US$35.8 million. This came alongside a 1 year total shareholder return of 74.34% contrasted with a...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Assessing Align Technology (ALGN) Valuation After Q1 2026 Earnings Beat And Product Updates

Align Technology (ALGN) is back in focus after its Q1 2026 earnings release, reaffirmed guidance, and a fresh wave of clear aligner and digital workflow product updates previewed at the AAO 2026 orthodontics conference. See our latest analysis for Align Technology. Despite the Q1 2026 earnings beat, reaffirmed guidance, and product updates previewed around AAO 2026, the stock’s 1-day share price return of 3.19% decline and 7-day share price return of 4.33% decline suggest some near term...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

MoonLake Immunotherapeutics (MLTX) Is Up 5.0% After FDA Alignment On Sonelokimab BLA Timing And Label Strategy

MoonLake Immunotherapeutics recently reported a positive final pre-BLA meeting with the U.S. FDA for sonelokimab in hidradenitis suppurativa, securing alignment on submission timing, label strategy including adolescent data, and a planned BLA filing by the end of September 2026 supported by US$357.9 million in cash and access to up to US$400 million in non-dilutive debt. An interesting aspect for investors is the potential for FDA Priority Review and a first U.S. commercial launch target in...
NasdaqGS:WDC
NasdaqGS:WDCTech

3 High ROE Stocks With Rock Solid Balance Sheets To Watch

Inflation jitters, higher energy costs and uneven global growth are putting a spotlight on company quality. When price pressures, shifting trade flows and rate expectations keep markets on edge, stocks with high return on equity, solid past performance and strong balance sheets can offer a more direct way to focus on business strength rather than noise. This article uses our Solid Balance Sheet and Fundamentals screener to highlight 3 stocks that fit this quality filter, helping you focus on...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

What Amazon.com (AMZN)'s New Supply Chain Services Launch Means For Shareholders

In late April and early May 2026, Amazon reported strong first-quarter results, with revenue of US$181.52 billion and net income of US$30.26 billion, and also launched Amazon Supply Chain Services to offer its full freight, distribution, fulfillment, and parcel shipping network to third-party businesses across multiple industries. This move effectively turns Amazon’s in-house logistics engine into a standalone service business, extending its reach beyond retail and deepening its presence in...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide (WRD) Valuation Check After Expanded Lenovo Autonomous Vehicle Collaboration

WeRide (WRD) stock is in focus after the company expanded its collaboration with Lenovo at Auto China 2026. The partners are targeting the joint deployment of 200,000 Level 4 autonomous vehicles globally over five years. See our latest analysis for WeRide. Despite the high profile Lenovo partnership and the upcoming AGM in June 2026, momentum in WeRide’s share price has been weak. The latest close was $7.39 and the year to date share price return was a decline of 21.3%, while the 1 year total...
NYSE:CFG
NYSE:CFGBanks

Do Citizens Financial (CFG) Dividends and AI Push Reveal a New Balance Sheet Playbook?

Citizens Financial Group recently declared a series of quarterly cash dividends on multiple preferred stock series, payable on July 6, 2026, to holders of record as of June 18, 2026, locking in income terms for those preferred investors. Alongside these capital return actions, Citizens is highlighting its growing private bank and efficiency push using AI and automation, which together frame how management is prioritizing both balance sheet strength and operating discipline. We’ll now examine...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

The Bull Case For Bentley Systems (BSY) Could Change Following Strong Q1 Recurring Revenue And New Term Loan

Bentley Systems, Incorporated reported past first-quarter 2026 results with revenue rising to US$424.18 million from US$370.54 million and net income edging up to US$95.39 million, alongside higher basic and diluted EPS from continuing operations. Beyond the headline growth, Bentley underscored robust subscription and recurring revenues, active AI product development, and enhanced balance sheet flexibility through a new US$550 million term loan maturing in 2029 and repayment of its 2026...
NYSE:OBK
NYSE:OBKBanks

A Look At Origin Bancorp (OBK) Valuation As It Expands Into Birmingham And Grows Its Southeast Footprint

Business expansion into Birmingham and what it means for Origin Bancorp stock Origin Bancorp (OBK) is extending its Southeast footprint with plans to enter Birmingham, adding to its banking centers across Texas, Louisiana, Mississippi, Alabama and the Florida Panhandle. This move follows the company’s 2024 push into South Alabama and the Florida Panhandle, where it has since opened three banking centers to support measured organic growth in the region. For investors, the Birmingham plan...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Is Lyft’s Q1 Earnings Miss And Expansion Pivot Altering The Investment Case For Lyft (LYFT)?

In early May 2026, Lyft reported first-quarter revenue of US$1,650.49 million and net income of US$14.25 million, alongside updates on international expansion, premium services, new partnerships with DoorDash and United Airlines, and progress in autonomous vehicle initiatives. These developments underline Lyft’s push to deepen customer loyalty and expand beyond North America, even as the company absorbs higher costs linked to acquisitions and growth initiatives. We’ll now examine how Lyft’s...
NYSE:FLG
NYSE:FLGBanks

Does Flagstar’s Dividend Resumption And Conference Messaging Reframe Its Capital Strength Story For FLG?

Flagstar Bank, National Association recently declared quarterly cash dividends across its common and three preferred share classes and, in early May 2026, its senior leadership presented at Barclays’ 18th Annual Americas Select Conference in London. The combination of resumed dividend payments and public commentary from the CEO and CFO underscores management’s emphasis on capital strength, disciplined credit risk, and transparent communication with investors following its return to...
NYSE:YELP
NYSE:YELPInteractive Media and Services

Yelp (YELP) Valuation Check After Earnings Beat And Expanding AI And Data Revenue Streams

Earnings beat and AI rollout put Yelp in focus Yelp (YELP) just posted first quarter results that came in ahead of Wall Street expectations, while reaffirming its full year outlook and spotlighting an ongoing push into AI powered products and new revenue streams. See our latest analysis for Yelp. The stock has picked up momentum recently, with a 30 day share price return of 11.37% and a 90 day share price return of 16.71%. However, the 1 year total shareholder return of a 20.26% decline and 5...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

Is CDW’s (CDW) AI-First Efficiency Push Reframing Its Margin Story More Than Its Growth Story?

In the first quarter of 2026, CDW Corporation reported past sales of US$5,679.8 million and net income of US$235.4 million, with both basic and diluted EPS from continuing operations rising to US$1.82 year on year, and declared a quarterly dividend of US$0.6300 per share payable on June 10, 2026. While CDW is benefiting from strong demand for infrastructure and AI-focused IT solutions, a higher hardware mix and softer cloud and SaaS contribution have pressured margins, prompting management...
NasdaqGM:ATRC
NasdaqGM:ATRCMedical Equipment

Assessing AtriCure (ATRC) Valuation After A Prolonged Share Price Pullback

Why AtriCure (ATRC) Is On Investors’ Radar Today AtriCure (ATRC) has drawn fresh attention as investors reassess the stock after a difficult stretch, with negative returns over the past month, past 3 months, year to date, and over the past year. See our latest analysis for AtriCure. At a share price of $27.80, AtriCure has seen weaker short term momentum, with a 30 day share price return of a 3.77% decline and a 1 year total shareholder return of a 10.84% loss pointing to prolonged...